-
CSR Summary Not Yet Available
-
NCT03253796
-
Primary Citation
-
Data Specification Not Yet Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameGolimumabProduct NameSIMPONI®Therapeutic AreaMuscle, Bone, and Cartilage DiseasesEnrollment323% Female33.7%% White100%
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberMK-8259-038Data PartnerJohnson & JohnsonCondition StudiedAxial SpondyloarthritisMean/Median Age (Years)32.5
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available